XML 55 R46.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, shares in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2016
Oct. 03, 2015
Oct. 01, 2016
Oct. 03, 2015
Stock Option Fair Value Assumptions and Methodology [Abstract]        
Stock option fair value assumptions, risk free interest rate     1.50% 1.40%
Stock option fair value assumptions, expected life in years     5 years 4 years
Stock option fair value assumptions, expected volatility     28.60% 29.10%
Stock option fair value assumptions, expected dividends     $ 0 $ 0
Weighted-average grant date fair value of options granted     $ 34.63 $ 30.85
Stock Options Outstanding Roll Forward [Abstract]        
Options outstanding at beginning of period     3,154  
Options granted     86 115
Options exercised     (700)  
Options canceled     (50)  
Options outstanding at end of period 2,490   2,490  
Weighted-average exercise price of options outstanding at beginning of period     $ 96.73  
Weighted-average exercise price of options granted     122.65 $ 121.33
Weighted-average exercise price of options exercised     76.98  
Weighted average exercise price of options canceled     109.55  
Weighted-average exercise price of options outstanding at end of period $ 102.92   $ 102.92  
Stock-Based Compensation Allocation of Recognized Period Expense [Line Items]        
Allocated stock-based compensation expense $ 8,367,000 $ 8,347,000 $ 32,604,000 $ 24,957,000
Incremental stock-based compensation cost due to acceleration of awards     $ 7,000,000  
Minimum        
Stock Options Outstanding Roll Forward [Abstract]        
Weighted-average exercise price of options outstanding at beginning of period     $ 38.09  
Weighted-average exercise price of options granted     117.68  
Weighted-average exercise price of options exercised     41.20  
Weighted average exercise price of options canceled     79.15  
Weighted-average exercise price of options outstanding at end of period $ 38.09   38.09  
Maximum        
Stock Options Outstanding Roll Forward [Abstract]        
Weighted-average exercise price of options outstanding at beginning of period     134.37  
Weighted-average exercise price of options granted     130.35  
Weighted-average exercise price of options exercised     113.36  
Weighted average exercise price of options canceled     128.93  
Weighted-average exercise price of options outstanding at end of period $ 134.37   $ 134.37  
Restricted Stock Plan        
Unvested Awards Roll Forward        
Shares granted     8  
Weighted-average grant date fair value of shares granted     $ 130.35  
Restricted Stock Unit Plan        
Stock-Based Compensation by Award [Line Items]        
Award vesting period     5 years  
Unvested Awards Roll Forward        
Unvested shares at beginning of period     497  
Shares granted     136  
Shares vested     (143)  
Shares forfeited     (11)  
Unvested shares at end of period 479   479  
Weighted-average grant date fair value of shares unvested at beginning of period     $ 104.16  
Weighted-average grant date fair value of shares granted     117.75  
Weighted-average grant date fair value of shares vested     98.76  
Weighted-average grant date fair value of shares forfeited     109.85  
Weighted-average grant date fair value of shares unvested at end of period $ 109.50   $ 109.50  
Cost of sales [Member]        
Stock-Based Compensation Allocation of Recognized Period Expense [Line Items]        
Allocated stock-based compensation expense $ 731,000 668,000 $ 2,058,000 1,990,000
Selling and administrative expenses [Member]        
Stock-Based Compensation Allocation of Recognized Period Expense [Line Items]        
Allocated stock-based compensation expense 6,944,000 6,626,000 27,526,000 19,686,000
Research and development expenses [Member]        
Stock-Based Compensation Allocation of Recognized Period Expense [Line Items]        
Allocated stock-based compensation expense $ 692,000 $ 1,053,000 $ 3,020,000 $ 3,281,000